Please do not leave this page until complete. This can take a few moments.
Marlborough-based biotech Advanced Cell Technology, which trades on the OTC Bulletin Board, reported a net loss of $5.7 million for the quarter ending March 31, up from $3.3 million a year ago.
The company also used more cash during the quarter – $4.8 million compared to $3.4 million.
ACT earns some revenue from licensing fees, but has not yet been profitable. It is in the midst of the first human stem cell trial approved by the U.S. Food and Drug Administration.
The company is developing treatments for Stargardt's macular dystrophy and dry age-related macular degeneration, which deteriorate layers of cells in the back of the eye.
“We are encouraged by the results we have seen from the early patients treated in each of our indications, and look forward to completing the trials on schedule,” CEO Gary Rabin said in a statement.
Rabin said in a recent interview that he wants to make a play for a NASDAQ listing, which would attract institutional investors. With that aim in mind, shareholders approved a reverse stock split in April.
Read more
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments